46 related articles for article (PubMed ID: 10381531)
1. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial.
Newsome PN; Fox R; King AL; Barton D; Than NN; Moore J; Corbett C; Townsend S; Thomas J; Guo K; Hull D; Beard HA; Thompson J; Atkinson A; Bienek C; McGowan N; Guha N; Campbell J; Hollyman D; Stocken D; Yap C; Forbes SJ
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):25-36. PubMed ID: 29127060
[TBL] [Abstract][Full Text] [Related]
2. Mobilization and collection of CD34(+) cells for autologous transplantation of peripheral blood hematopoietic progenitor cells in children: analysis of two different granulocyte-colony stimulating factor doses.
Eid KA; Miranda EC; Aguiar Sdos S
Rev Bras Hematol Hemoter; 2015; 37(3):160-6. PubMed ID: 26041417
[TBL] [Abstract][Full Text] [Related]
3. Increased expansion of V alpha 24+ T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation.
Asada-Mikami R; Heike Y; Harada Y; Kanai S; Ikarashi Y; Kato K; Shirakawa K; Takaue Y; Abe T; Wakasugi H
Cancer Sci; 2003 Apr; 94(4):383-8. PubMed ID: 12824909
[TBL] [Abstract][Full Text] [Related]
4. Take a spin: Apheresis in the care of adult leukaemia patients.
Ai J
Best Pract Res Clin Haematol; 2023 Jun; 36(2):101467. PubMed ID: 37353291
[TBL] [Abstract][Full Text] [Related]
5. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency.
Zekri AR; Salama H; Medhat E; Musa S; Abdel-Haleem H; Ahmed OS; Khedr HA; Lotfy MM; Zachariah KS; Bahnassy AA
Stem Cell Res Ther; 2015 Jun; 6(1):118. PubMed ID: 26062731
[TBL] [Abstract][Full Text] [Related]
6. Lactate-a new player in G-CSF-induced mobilization of hematopoietic stem/progenitor cells.
Ordonez-Moreno LA; Haddad M; Chakrabarti P; Khatib-Massalha E; Fruchtman H; Boura-Halfon S; Petrovich-Kopitman E; Lapidot T; Kollet O
Leukemia; 2023 Aug; 37(8):1757-1761. PubMed ID: 37138018
[No Abstract] [Full Text] [Related]
7. Incidence of cardiovascular disease in healthy Swedish peripheral blood stem cell donors - a nationwide study.
Pahnke S; Hägglund H; Larfors G
Bone Marrow Transplant; 2024 Mar; 59(3):403-408. PubMed ID: 38212669
[TBL] [Abstract][Full Text] [Related]
8. Treatment-Induced Bone Marrow Enhancement at MRI in Breast Cancer Patients Receiving Granulocyte-Colony Stimulating Factor Adjunct to Chemotherapy.
Sorin V; Bokov I; Haisraely O; Ben-David MA; Faermann R; Sklair-Levy M
Acad Radiol; 2023 Sep; 30 Suppl 2():S9-S15. PubMed ID: 37277268
[TBL] [Abstract][Full Text] [Related]
9. Revolutionizing Stroke Recovery: Unveiling the Promise of Stem Cell Therapy.
Panos LD; Bargiotas P; Arnold M; Hadjigeorgiou G; Panos GD
Drug Des Devel Ther; 2024; 18():991-1006. PubMed ID: 38567255
[TBL] [Abstract][Full Text] [Related]
10. Effects of associated SCF and G-CSF on liver injury two weeks after liver damage: A model induced by thioacetamide administration.
Esmaili M; Qujeq D; Yoonesi AA; Feizi F; Ranaee M
Mol Biol Res Commun; 2014 Jun; 3(2):141-147. PubMed ID: 30805380
[TBL] [Abstract][Full Text] [Related]
11. Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors.
Phou S; Perez-Alvarez I; Morgan M; Contreras DA; Ben-Aderet M; Gaddam E; Paquette R; Vescio R; Pepkowitz SH; Gibb DR; Zabner R; Klapper EB
Transfusion; 2023 Apr; 63(4):861-866. PubMed ID: 36880384
[TBL] [Abstract][Full Text] [Related]
12. Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.
León-Mateos L; Vieito M; Anido U; López López R; Muinelo Romay L
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657044
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.
Jaeger BA; Jueckstock J; Andergassen U; Salmen J; Schochter F; Fink V; Alunni-Fabbroni M; Rezai M; Beck T; Beckmann MW; Friese K; Friedl TW; Janni W; Rack B
Biomed Res Int; 2014; 2014():491459. PubMed ID: 24800234
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.
Müller AM; Kohrt HE; Cha S; Laport G; Klein J; Guardino AE; Johnston LJ; Stockerl-Goldstein KE; Hanania E; Juttner C; Blume KG; Negrin RS; Weissman IL; Shizuru JA
Biol Blood Marrow Transplant; 2012 Jan; 18(1):125-33. PubMed ID: 21767515
[TBL] [Abstract][Full Text] [Related]
15. High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR.
Perey L; Benhattar J; Peters R; Jaunin P; Leyvraz S
Br J Cancer; 2001 Nov; 85(11):1713-21. PubMed ID: 11742493
[TBL] [Abstract][Full Text] [Related]
16. Circulating breast cancer cells are frequently apoptotic.
Méhes G; Witt A; Kubista E; Ambros PF
Am J Pathol; 2001 Jul; 159(1):17-20. PubMed ID: 11438448
[TBL] [Abstract][Full Text] [Related]
17. Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.
Franklin WA; Glaspy J; Pflaumer SM; Jones RB; Hami L; Martinez C; Murphy JR; Shpall EJ
Blood; 1999 Jul; 94(1):340-7. PubMed ID: 10381531
[TBL] [Abstract][Full Text] [Related]
18. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
[TBL] [Abstract][Full Text] [Related]
19. Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans.
Begley CG; Basser R; Mansfield R; Thomson B; Parker WR; Layton J; To B; Cebon J; Sheridan WP; Fox RM; Green MD
Blood; 1997 Nov; 90(9):3378-89. PubMed ID: 9345020
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
